12 completed, 2 recruiting, 2 terminated, 2 withdrawn. 19 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 19 | Completed 12, Recruiting 2, Terminated 2, Withdrawn 2, Unknown 1 |
Follow Nausea and Vomiting: new trials by email Literature Review of Nausea and Vomiting trials Research Report on Nausea and Vomiting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexmedetomidine and Propofol for Sedation in Cataract Surgery. Dexmedetomidine (DEX), Propofol (PRO), Fentanyl (FEN) - Sedation, Cataract | Not applicable | Recruiting | Saint-Joseph University | 1000 | 2025-11-09 | 2026-04-29 |
| Exploring the Effect of Aromatherapy Aromatherapy plus standard of care, Standard of Care Only - Anxiety, Labor Pain | Not applicable | Completed | Baptist Health South Florida | 138 | 2025-10-15 | 2026-10-06 |
| The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV Palonosetron hydrochloride capsules - Nausea and Vomiting | Not applicable | Recruiting | Xijing Hospital | 1060 | 2022-05-16 | 2023-01-19 |
| The Impact of Oral Cryotherapy and Chewing Gum Interventions Oral Cryotherapy Group (Group 1), Chewing Gum Group (Group 2) - Breast Cancer, Nausea and Vomiting | Not applicable | Completed | Hacettepe University | 135 | 2021-06-01 | 2025-08-28 |
| Comparison of the Effect of Ondansetron and Combined Ondansetron and Betahistine on Postoperative Nausea and Vomiting After Gynecological Laparoscopy ondansetron, ondansetron-betahistine - Nausea and Vomiting | Not applicable | Completed | Yonsei University | 168 | 2013-12-01 | 2019-03-28 |
| Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension ramosetron, ondansetron, placebo - Hypotension, Shivering | Not applicable | Unknown | Seoul National University Hospital | 100 | 2012-08-01 | 2012-08-20 |
| Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy questionnaire administration, therapeutic touch, management of therapy complications - Anxiety Disorder, Fatigue | Not applicable | Completed | Wake Forest University Health Sciences | 244 | 2012-02-01 | 2018-07-05 |
| Supportive Intervention Programs Study Yoga therapy, questionnaire administration, quality-of-life assessment - Fatigue, Nausea and Vomiting | Not applicable | Completed | Wake Forest University | 15 | 2011-06-01 | 2018-08-15 |
| Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Adjuvant Therapy, Aprepitant, Carboplatin - Nausea and Vomiting, Ovarian Brenner Tumor | Not applicable | Terminated | Gynecologic Oncology Group | 4 | 2011-06-01 | 2018-05-22 |
| Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer questionnaire administration, hypnotherapy, therapeutic conventional surgery - Anxiety Disorder, Breast Cancer | Not applicable | Completed | City of Hope Medical Center | 20 | 2008-08-01 | 2011-03-07 |
| Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer medical chart review, questionnaire administration, fatigue assessment and management - Breast Cancer, Fatigue | Not applicable | Withdrawn | City of Hope Medical Center | 2008-07-01 | 2013-02-01 | |
| Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer medical chart review, questionnaire administration, fatigue assessment and management - Fatigue, Nausea and Vomiting | Not applicable | Completed | City of Hope Medical Center | 125 | 2008-07-01 | 2010-10-01 |
| Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer aprepitant, ondansetron hydrochloride - Myeloproliferative Disorders, Leukemia | Not applicable | Withdrawn | Vanderbilt-Ingram Cancer Center | 2007-08-01 | 2013-04-02 | |
| Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy Aprepitant, Dexamethasone, Dolasetron Mesylate - Malignant Digestive System Neoplasm, Nausea and Vomiting | Not applicable | Terminated | University of Southern California | 19 | 2006-04-19 | 2017-03-28 |
| Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer palonosetron hydrochloride, cyclophosphamide, dexamethasone - Male Breast Cancer, Nausea and Vomiting | Not applicable | Completed | University of Washington | 41 | 2006-01-01 | 2017-07-11 |
| Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy acupressure therapy, sham intervention - Nausea and Vomiting, Unspecified Childhood Solid Tumor, Protocol Specific | Not applicable | Completed | Wake Forest University Health Sciences | 28 | 2005-04-01 | 2018-08-10 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant Aprepitant, Cyclophosphamide, Dexamethasone - Breast Cancer, Chronic Myeloproliferative Disorders | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 40 | 2004-10-01 | 2016-03-15 |
| Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer Quality-of-Life Assessment, Yoga - Alopecia, Anxiety | Not applicable | Completed | Albert Einstein College of Medicine | 399 | 2001-02-08 | 2023-05-31 |
| Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy ondansetron - Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific | Not applicable | Completed | University of Rochester | 2000-08-01 | 2013-03-05 |
Nausea (19) · Vomiting (19) · Breast Neoplasms (6) · Pain (6) · Fatigue (5) · Anxiety Disorders (4) · Burkitt Lymphoma (2) · Hodgkin Disease (2) · Leukemia (2) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (2) · Leukemia, Myelomonocytic, Chronic (2) · Leukemia, Neutrophilic, Chronic (2)
Pathological Conditions, Signs and Symptoms (19) · Signs and Symptoms (19) · Signs and Symptoms, Digestive (19) · Neoplasms (11) · Neoplasms by Site (11) · Neurologic Manifestations (7) · Breast Diseases (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Cardiovascular Diseases (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Mental Disorders (4) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3)
Ondansetron (5) · Aprepitant (4) · Calcium Dobesilate (4) · Dexamethasone (4) · Therapeutics (3) · dexamethasone 21-phosphate (3) · dexamethasone acetate (3) · Cyclophosphamide (2) · Granisetron (2) · Palonosetron (2) · Psychiatric Rehabilitation (2) · Yoga (2) · auricularum (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Acupressure (1)
City of Hope Medical Center (3) · Wake Forest University Health Sciences (2) · Albert Einstein College of Medicine (1) · Baptist Health South Florida (1) · Barbara Ann Karmanos Cancer Institute (1) · Gynecologic Oncology Group (1) · Hacettepe University (1) · Saint-Joseph University (1) · Seoul National University Hospital (1) · University of Rochester (1) · University of Southern California (1) · University of Washington (1) · Vanderbilt-Ingram Cancer Center (1) · Wake Forest University (1) · Xijing Hospital (1)
United States (12) · South Korea (2) · China (1) · Lebanon (1) · Turkey (Türkiye) (1)
Marcia Grant, RN, DNSc, FAAN (2) · Alyson Moadel (1) · Barbara A. Murphy, MD (1) · Betty Chan (1) · Gary R. Morrow, PhD, MS (1) · Hannah Linden (1) · Lisa Hodges (1) · Liu Hong, master (1) · Michael Lew, MD (1) · Muneer H. Abidi, MD (1) · Naji Abou Jalad, MD (1) · Stephanie J Sohl, PhD (1) · Steven Plaxe (1) · Thomas Williams McLean, MD (1)
P30CA033572 (3), P30CA013330 (1), P30CA014089 (1), P30CA022453 (1), R03CA088598 (1), U10CA101165 (1)